Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Stegeman

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Arthritis and Rheumatism|November 11, 1999
Comparison of Dutch and US patients' perceptions of the effects of Wegener's granulomatosis on health, function, income, and interpersonal relationships: comment on the article by Hoffman et alM M Boomsma, C A Stegeman, J W Tervaert
Clinical and Experimental Immunology|August 1, 1995
Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCAA H Mulder, C A Stegeman, C G Kallenberg
Current Opinion in Rheumatology|February 4, 1998
Silicon exposure and vasculitisJ W Tervaert, C A Stegeman, C G Kallenberg
Current Opinion in Nephrology and Hypertension|February 27, 2001
Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitisJ W Tervaert, C A Stegeman, C G Kallenberg
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 1, 1996
Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitidesJ W Tervaert, C A Stegeman, C G Kallenberg
Annales De Medecine Interne|January 1, 1994
Anti-neutrophil cytoplasmic antibodies: tools for diagnosis and follow-up in systemic vasculitisC A Stegeman, J W Tervaert, C G Kallenberg
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 1997
Co-trimoxazole and Wegener's granulomatosis: more than a coincidence?C A Stegeman, J W Tervaert, C G Kallenberg
APMIS. Supplementum|January 1, 1990
Criteria for disease activity in Wegener's granulomatosis: a requirement for longitudinal clinical studiesC G Kallenberg, J W Tervaert, C A Stegeman
Clinical Nephrology|September 17, 2008
Comment on Ibernon et al. Clin Nephrol 2008; 69: 395-401P M Stassen, J W Cohen Tervaert, C A Stegeman
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1995
Treatment of idiopathic membranous nephropathy: the dilemma of who, when, and howC A Stegeman, D de Zeeuw, P E de Jong
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Arthritis and Rheumatism|November 11, 1999
Comparison of Dutch and US patients' perceptions of the effects of Wegener's granulomatosis on health, function, income, and interpersonal relationships: comment on the article by Hoffman et alM M Boomsma, C A Stegeman, J W Tervaert
Clinical and Experimental Immunology|August 1, 1995
Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCAA H Mulder, C A Stegeman, C G Kallenberg
Current Opinion in Rheumatology|February 4, 1998
Silicon exposure and vasculitisJ W Tervaert, C A Stegeman, C G Kallenberg
Current Opinion in Nephrology and Hypertension|February 27, 2001
Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitisJ W Tervaert, C A Stegeman, C G Kallenberg
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 1, 1996
Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitidesJ W Tervaert, C A Stegeman, C G Kallenberg
Annales De Medecine Interne|January 1, 1994
Anti-neutrophil cytoplasmic antibodies: tools for diagnosis and follow-up in systemic vasculitisC A Stegeman, J W Tervaert, C G Kallenberg
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 1997
Co-trimoxazole and Wegener's granulomatosis: more than a coincidence?C A Stegeman, J W Tervaert, C G Kallenberg
APMIS. Supplementum|January 1, 1990
Criteria for disease activity in Wegener's granulomatosis: a requirement for longitudinal clinical studiesC G Kallenberg, J W Tervaert, C A Stegeman
Clinical Nephrology|September 17, 2008
Comment on Ibernon et al. Clin Nephrol 2008; 69: 395-401P M Stassen, J W Cohen Tervaert, C A Stegeman
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1995
Treatment of idiopathic membranous nephropathy: the dilemma of who, when, and howC A Stegeman, D de Zeeuw, P E de Jong
Pageof 11